Cerus (STU:CU2) Marketable Securities : €47.5 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Cerus Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Cerus's Marketable Securities for the quarter that ended in Mar. 2024 was €47.5 Mil.

Cerus's annual Marketable Securities declined from Dec. 2021 (€71.3 Mil) to Dec. 2022 (€62.8 Mil) and declined from Dec. 2022 (€62.8 Mil) to Dec. 2023 (€49.7 Mil).

Cerus Marketable Securities Historical Data

The historical data trend for Cerus's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cerus Marketable Securities Chart

Cerus Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

45.66

79.73

71.33

62.84

49.71

Cerus Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															62.65	58.95	57.74	49.71	47.52

Cerus Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Cerus (STU:CU2) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Cerus Marketable Securities Related Terms

Thank you for viewing the detailed overview of Cerus's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cerus (STU:CU2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cerus Corp (STU:CU2) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

CERS:USA

Address

1220 Concord Avenue, Suite 600, Concord, CA, USA, 94520

Website

http://www.cerus.com

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Cerus (STU:CU2) Headlines

No Headlines